Previous close | 574.59 |
Open | 578.00 |
Bid | 575.71 x 800 |
Ask | 576.05 x 800 |
Day's range | 565.23 - 586.46 |
52-week range | 415.60 - 603.82 |
Volume | |
Avg. volume | 1,456,108 |
Market cap | 220.094B |
Beta (5Y monthly) | 0.80 |
PE ratio (TTM) | 37.30 |
EPS (TTM) | 15.46 |
Earnings date | 24 Apr 2024 |
Forward dividend & yield | 1.56 (0.27%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | 609.83 |
Thermo Fisher's (TMO) first-quarter 2024 revenues register year-over-year growth driven by new product launches.
On Wednesday, Thermo Fisher Scientific Inc. (NYSE: TMO) posted a first-quarter revenue of $10.34 billion, down 3% year over year, beating the consensus of $10.17 billion. Organic revenue was 4% lower, and core organic revenue growth declined by 3%. Revenue from the Life Sciences Solutions Segment declined by 12.5% to $2.29 billion. Analytical Instruments Segment sales were down 2.1% to $1.69 billion. Specialty Diagnostics Segment revenues were almost flat at $1.1 billion, and Laboratory Products
In this article, we will take a look at the 15 countries with the negative population growth in the world. If you want to skip our discussion on the population trends, you can go directly to the 5 Countries with the Negative Population Growth in the World. According to data from the Institute for Health […]